Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Acta cir. bras ; 34(8): e201900803, 2019. graf
Article in English | LILACS | ID: biblio-1038126

ABSTRACT

Abstract Purpose To evaluate changes in the quantity of elastic fibers in the corpora cavernosa of rats during the natural aging process, and to assess the degree of this change by determining volumetric density (Vv) at different ages via stereological analysis. Methods Forty-eight rats, raised under similar conditions, were subjected to the natural aging process and divided into four groups (G1 to G4), according to age at the time of penectomy (6, 9, 12, and 24 months, respectively). Histological sections of the middle segment of the penis were stained with Weigert's resorcin-fuchsin, and the volumetric density (Vv) of elastic fibers of the corpora cavernosa were determined via stereological analysis. Results There were no statistically significant differences in Vv among groups G1, G2, and G3. These three groups were therefore considered as a single group. The mean Vv of this group showed a statistically significant reduction compared to that of G4 (0.16 vs. 0.11, p<0.05). Conclusion Natural aging in rats was responsible for a reduction in volumetric density of elastic fibers of the corpora cavernosa (approximately 30% decrease in Vv) during senescence.


Subject(s)
Animals , Male , Rats , Penis/cytology , Aging/physiology , Endothelial Cells/physiology , Elastic Tissue/ultrastructure , Penis/physiology , Aging/pathology , Collagen/physiology , Collagen/ultrastructure , Rats, Wistar , Models, Animal , Elastic Tissue/physiology , Elastic Tissue/pathology , Erectile Dysfunction/physiopathology
2.
Arq. bras. oftalmol ; 81(2): 87-91, Mar.-Apr. 2018. graf
Article in English | LILACS | ID: biblio-950440

ABSTRACT

ABSTRACT Purpose: Donated corneas are classified as tectonic if there are defects within any layers of the cornea which would prevent a satisfactory visual outcome after transplantation. This study aimed to evaluate whether some tectonic corneas have sufficient endothelial characteristics to allow their use in posterior lamellar keratoplasty, and explored their reclassification for use in this sight-improving procedure. Methods: A retrospective review of all corneal tissues preserved by the Sorocaba Eye Bank from January to April of 2014 was performed. All donated corneas classified as tectonic were included. Endothelial tissue was defined as healthy and viable for posterior lamellar keratoplasty if endothelial cell density was ≥2000 cells/mm2. Additional parameters analyzed included Descemet folds and stretch marks, loss of endothelial cells, corneal endothelial polymegathism/ pleomorphism, pseudo-guttata, and reflectivity. Results: During the study period, 2,847 corneas were preserved, of which 423 (14.85%) were classified as tectonic. Of these, 87 (20.56%) were reported as having endothelial viability and were included in the posterior lamellar keratoplasty group. Average corneal endothelial cell density of this group was 2,471 SD ± 256 cells/mm2 (range 2012-2967 cells/mm2). Conclusion: A significant number of corneas classified as tectonic showed endothelial viability and were included in the posterior lamellar keratoplasty group (20.56%). Despite stromal and/or epithelial alterations, these corneas could have been potentially distributed for posterior lamellar transplantation to improve vision, thus reducing the corneal transplantation waiting period. This study highlights how corneal tissue reclassification could increase the potential amount of corneal tissue available for optical transplantation.


RESUMO Objetivo: Avaliar a vitalidade endotelial das córneas classificadas como tectônicas e discutir a viabilidade de seu uso na ceratoplastia lamelar posterior. Métodos: Realizou-se uma revisão retrospectiva de todos os tecidos corneanos preservados pelo Banco de Olhos Sorocaba de janeiro a abril de 2014. Todas as córneas doadas classificadas como tectônicas foram incluídas e avaliadas com ênfase na vitalidade endotelial. Os parâmetros de avaliação da lâmpada de fenda de cada córnea e densidade de células endoteliais medidos por microscópio especular foram registrados: córneas que apresentavam vitalidade endotelial apesar de alterações no estroma e/ou no epitélio foram selecionadas e incluídas em um grupo denominado grupo lamelar posterior. O tecido endotelial foi definido como saudável e viável para a ceratoplastia lamelar posterior, se houvesse uma densidade de células endoteliais ≥2.000 células/mm2. Outros parâmetros também foram analisados, incluindo; estrias ou pregas na Descemet, perda de células endoteliais, polimegatismo e pleomorfismo endotelial, pseudo-guttata e reflexividade endotelial. Resultados: Durante o período do estudo, foram preservadas 2.847 córneas, das quais 423 (14,85%) foram classificadas como tectônicas. Dessas, 87 (20,56%) apresentaram vitalidade endotelial e foram incluídos no grupo lamelar posterior. A densidade média das células endoteliais da córnea deste grupo era de 2.471 SD ± 256 células/mm2, variando de 2.012 a 2.967 células/mm2. Conclusão: Um número significativo de córneas classificadas como tectônicas apresentaram vitalidade endotelial e foram incluídas no grupo lamelar posterior (20,56%). Apesar de alterações estromais e/ou epiteliais, estas córneas poderiam ter sido potencialmente distribuídas para transplantes lamelares posteriores com finalidade ótica, otimizando a disponibilidade de tecidos, com impacto positivo na saúde pública.


Subject(s)
Humans , Endothelium, Corneal/physiology , Corneal Transplantation/standards , Cornea , Endothelial Cells/physiology , Eye Banks/standards , Tissue Preservation/standards , Tissue and Organ Procurement/standards , Brazil , Endothelium, Corneal/transplantation , Cell Count , Cell Survival/physiology , Retrospective Studies
3.
Braz. j. med. biol. res ; 51(2): e6768, 2018. graf
Article in English | LILACS | ID: biblio-889019

ABSTRACT

This study aimed to investigate the mechanism of hypoxia-inducible factor-1 alpha (HIF-1α) mediated hypoxia-induced permeability changes in bladder endothelial cells. Models of in vitro hypoxic cell culture of bladder cancer, bladder cancer cells with low HIF-1α expression and HIF-1α RNA interference (RNAi) expression vector were established. Western blot and reverse transcription polymerase chain reaction (RT-PCR) were used to detect the expression of HIF-1α and vascular endothelial growth factor (VEGF) in each group. Bladder cell permeability was determined. Results showed that protein and mRNA expression of HIF-1α and VEGF at 3 and 12 h of hypoxia were significantly higher than normal control (P<0.05), and peaked at 12 h. HIF-1α and VEGF expression in the hypoxic group and hypoxic+3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole (YC-1) group were significantly higher than normal control (P<0.05), while expression in the hypoxic+YC-1 group was significantly lower than the hypoxic group (P<0.05). Bladder cell permeability in the hypoxic and hypoxic+YC-1 group were significantly increased compared to normal control (P<0.05), while in the hypoxic+YC-1 group was significantly decreased compared to the hypoxic group (P<0.05). Most of the cells in the stably transfected HIF-1α RNAi expression vector pcDNA6.2-GW/EmGFP-miR-siHIF-1α expressed green fluorescence protein (GFP) under fluorescence microscope. pcDNA6.2-GW/EmGFP-miR-siHIF-1α could significantly inhibit HIF-1α gene expression (P<0.05). HIF-1α and VEGF expression in the hypoxic group and siHIF-1α hypoxic group were significantly higher than normal group (P<0.05), while expression in the siHIF-1α hypoxic group was significantly lower than the hypoxic group (P<0.05). Findings suggest that HIF-1α is an important factor in the increase of bladder cancer cell permeability.


Subject(s)
Animals , Rats , Urinary Bladder Neoplasms/metabolism , Endothelial Cells/physiology , Vascular Endothelial Growth Factor A/physiology , Hypoxia-Inducible Factor 1, alpha Subunit/physiology , Tumor Hypoxia/physiology , Permeability , Gene Expression Regulation, Neoplastic/physiology , Blotting, Western , RNA Interference , Cell Line, Tumor , Endothelial Cells/pathology , Hypoxia-Inducible Factor 1, alpha Subunit/analysis , Real-Time Polymerase Chain Reaction
4.
Int. j. morphol ; 33(4): 1348-1354, Dec. 2015. ilus
Article in Spanish | LILACS | ID: lil-772320

ABSTRACT

La vasculogénesis es controlada por una serie de mecanismos que se activan en función del tiempo y del espacio durante el desarrollo embrionario. Múltiples son las vías de señalización implicadas en las etapas del proceso vasculogénico, las que se inician con estímulos angiogénicos desde el mesodermo o desde el endodermo para dar origen a los angioblastos (células progenitoras endoteliales). Proteínas como el factor de crecimiento vascular endotelial (VEGF), factor de crecimiento fibroblastico 2 (FGF2), entre otras, constituyen factores claves en la inducción de este proceso. Posteriormente, los angioblastos deben migrar para dar origen a los vasos primitivos, proceso en el que participan factores atrayentes y repulsivos que orientarán la dirección de su migración. Adicionalmente, los mecanismos de diferenciación arterio-venosa, regulados por la vía de señalización Hedgegog, VEGF y Notch, son determinados antes del inicio de la circulación, lo que sugiere que el destino de la célula endotelial se encuentra genéticamente determinado. Por su parte, los procesos de remodelación y proliferación vascular post natal, son generados a través de la formación de nuevos vasos a partir de vasos pre existentes (angiogénesis). El factor angiogénico que induce los cambios morfológicos y funcionales en las células endoteliales es el VEGFA, las cuales, adquieren la capacidad de direccionar al nuevo vaso en desarrollo. Uno de los principales estímulos físicos que modifica el patrón de crecimiento de los lechos vasculares es el estrés de flujo, el cual, es susceptible de ser modificado por situaciones de estrés como el ejercicio físico. En la presente revisión, se abordan los principales mecanismos implicados en la regulación fisiológica de la vasculogénesis y angiogénesis. Adicionalmente, se discutirán los mecanismos que sustentan la respuesta vascular inducida por estrés de flujo, considerando su rol en el establecimiento de los patrones de crecimiento vascular.


Vasculogenesis is controlled by a number of mechanisms that are activated as a function of time and space during embryonic development. Multiple signaling pathways are involved in the stages of vasculogenic process, which start with angiogenic stimuli from the mesoderm or the endoderm to give rise to angioblasts (endothelial progenitor cells). Proteins such as vascular endothelial growth factor (VEGF), fibroblast growth factor 2 (FGF2), among others, are key factors in the induction of this process. Subsequently, the angioblasts must migrate to give birth to primitive vessels, a process that involves attractive and repulsive factors that guide the direction of their migration. Additionally, arterial and venous differentiation regulated hedgegog signaling pathway, VEGF and Notch are determined before the start of circulation, suggesting that the endothelial cell fate is determined genetically. On the other hand, the processes of remodeling and postnatal vascular proliferation are generated through the formation of new vessels from pre-existing vessels (angiogenesis). The angiogenic factor that induces morphological and functional changes in the endothelial cells is the VEGFA, these vessels acquire the ability to address the new developing vessel. One of the main physical stimuli that modify the growth pattern of the vascular beds is the shear stress, which is modified by exercise. In this review, the main mechanisms involved in the physiological regulation of vasculogenesis and angiogenesis are addressed. Additionally, the mechanisms underlying the vascular response induced by shear stress will be discussed, considering its role in establishing patterns of vascular growth.


Subject(s)
Humans , Angiogenesis Modulating Agents , Endothelial Cells/physiology , Neovascularization, Physiologic/physiology , Exercise , Stress, Mechanical
5.
São Paulo; s.n; s.n; abr. 2015. 175 p. tab, graf, ilus.
Thesis in Portuguese | LILACS | ID: biblio-834158

ABSTRACT

O melanoma é uma neoplasia de pele invasivo, com maior taxa de morte, sem tratamento efetivo. Nanocápsulas poliméricas de núcleo lipídico (LNC) tem sido empregadas com sucesso como carreadores de fármacos hidrofóbicos. Como o eugenol é um composto hidrofóbico com atividades antiproliferativas e pró-apoptóticas em células cancerosas, visamos avaliar os efeitos dos tratamentos com acetileugenol (AC), LNC ou LNC contendo acetileugenol (LNC-AC) em modelo de melanoma in vivo em camundongos C57B6, e a citotoxicidade dos mesmos em células endoteliais (HUVEC) e de melanoma (SK-Mel-28) in vitro. Os resultados obtidos mostraram que: 1) tratamentos i.p. com as LNC ou com LNC-AC (50 mg/kg, 3-10 dia de indução do tumor) induziram toxicidade sistêmica e, somente o tratamento com LNC inibiu o desenvolvimento do melanoma. O tratamento com LNC, mas não com a mistura de triglicerídeos de cadeia média, por via oral, inibiu o desenvolvimento tumoral, sem toxicidade. Adicionalmente, os tratamentos com AC, LNC ou LNC-AC não foram eficazes quando administrados em fase tardia de evolução tumoral (50 mg/kg, 7-17 dia de indução do tumor, via oral); 2) os tratamentos agudos com AC, LNC ou LNC-AC (20 mg/kg, 200 µL, e.v.) não alteraram o número de leucócitos circulantes, mas os tratamentos com LNC ou com LNC-AC reduziram o comportamento de rolling dos leucócitos em vênulas póscapilares do músculo cremaster e causaram hemólise, sendo que este último efeito também foi observado após tratamento in vitro em hemácias murinas; 3) Os estudos in vitro mostraram que as LNC e LNC-AC foram captadas pelas células HUVEC e SK-Mel-28 após 1 hora de incubação; que a incubação com LNC-AC induziu apoptose tardia e necrose com maior eficácia em SK-Mel-28 do que em HUVEC; que as incubações com LNC ou LNC-AC exerceram efeitos antiproliferativos, induzindo parada na fase G2/M do ciclo celular das duas linhagens de células avaliadas; que somente a incubação com AC ou LNC-AC inibiu a adesão ao Matrigel® com maior eficácia na linhagem SK-Mel-28 do que HUVEC; que somente a incubação com as LNC reduziram a expressão de VCAM-1 em HUVEC e que as incubações com LNC ou LNC-AC reduziram a expressão de ß3 integrina em SK-Mel- 28; que nenhum dos tratamentos alterou a migração celular das HUVEC ou SK-Mel- 28; que somente a incubação com LNC-AC reduziu os níveis de espécies reativas de oxigênio em HUVEC e SK-Mel-28; que a incubação com LNC ou LNC-AC aumentou a produção de óxido nítrico (NO) pelas duas linhagens de células avaliadas; que o tratamento com L-NAME reverteu os níveis de NO e a inibição sobre a proliferação celular induzida pela incubação com LNC ou LNC-AC e; que o tratamento de células de melanoma murino com LNC ou LNC-AC parece alterar a polarizar os neutrófilos para o fenótipo N1. Associados, os resultados obtidos mostram o tratamento oral com LNC inibe o crescimento do melanoma sem induzir efeitos tóxicos, e que este efeito benéfico pode ser dependente, pelo menos em parte, da nanoencapsulação dos triglicerídios de cadeia média e da supraestrutura da formulação, com toxicidade direta sobre as células de melanoma e possível modulação do microambiente tumoral


Melanoma is the most invasive skin cancer, with high rates of death without effective treatment. Polymeric lipid-core nanocapsules (LNC) has been successfully used as carriers of hydrophobic drugs. As eugenol is an hydrophobic compound with antiproliferative and pro-apoptotic activity in cancer cells, here we aimed to evaluate the effects of treatments with acetyleugenol (AC), LNC or LNC containing acetyleugenol (LNC-AC) in an in vivo melanoma model in C57BL6 mice and the cytotoxicity of the treatments in vitro, using endothelial (HUVEC) and melanoma (SK-Mel- 28) cells. The results obtained showed that: 1) i.p. treatments with LNC or LNCAC (50 mg/kg, 3-10 days of tumor injection) induced systemic toxicity and, only the treatment with LNC inhibited the melanoma development. Treatment with LNC, but not with mix of triglycerides of medium chain, by oral route, inhibited the tumor development, without toxicity. In addition, the treatments with AC, LNC or LNC-AC were not effective when administered in the late stage of tumor evolution (50 mg/kg, 10-20 days of tumor induction, oral route); 2) the acute treatments with AC, LNC or LNC-AC (20 mg/kg, 200 µL, intravenous route) did not altered the number of circulating leukocytes, but the treatments with LNC or LNC-AC reduced the rolling behavior of leukocytes in postcapillary venules of the cremaster muscle and induced hemolysis. The latter effect was also observed after in vitro treatment using murine erythrocytes; 3) In vitro studies showed that the LNC and LNC-AC suffered uptake by HUVEC and SK-Mel-28 cells after 1 hour of incubation; that the incubation with LNC-AC induced late apoptosis and necrosis more effectively in SK-Mel-28 than in HUVEC cells; that the incubation with LNC or LNC-AC presented antiproliferative effects, by inducing G2M arrest in cell cycle in both cells lines evaluated; that only the incubation with AC or LNC-AC inhibited the adhesion in Matrigel® with more efficaccy in SK-Mel-28 than in HUVEC cells; that only incubtion with LNC reduced the VCAM-1 expression in HUVEC and the incubation with LNC or LNC-AC reduced the ß3 integrin expression in SK-Mel-28 cells; that any treatment affected the HUVEC or SK-Mel- 28 migration; that only the incubation with LNC-AC reduced the levels of reactive species of oxygen in HUVEC and SK-Mel-28 cells; that the incubation with LNC or LNC-AC increased the nitric oxide (NO) production by both cell lines used; that the treatment with L-NAME reversed the NO levels and the inhibition on cell proliferation induced by incubation with LNC or LNC-AC and; that the in vitro treatment of murine with LNC or LNC-AC altered the neutrophil polarization to N1 phenotype. Together, results obtained show that the oral treatment with LNC inhibit the melanoma growth without any toxic effect, and that the beneficial effect could be dependent, at least in part, of nanoencapsulation of medium chain triglycerides and the supraestrucuture of the formulation, with direct toxicity on melanoma cells and possible modulation of tumor microenvironment


Subject(s)
Mice , Endothelial Cells/physiology , In Vitro Techniques/instrumentation , Melanoma/genetics , Nanocapsules/statistics & numerical data , Eugenol/analysis , Neutrophils/classification
6.
Arq. bras. cardiol ; 104(3): 185-194, 03/2015. tab, graf
Article in English | LILACS | ID: lil-742788

ABSTRACT

Background: Ruthenium (Ru) tetraamines are being increasingly used as nitric oxide (NO) carriers. In this context, pharmacological studies have become highly relevant to better understand the mechanism of action involved. Objective: To evaluate the vascular response of the tetraamines trans-[RuII(NH3)4(Py)(NO)]3+, trans-[RuII(Cl)(NO) (cyclan)](PF6)2, and trans-[RuII(NH3)4(4-acPy)(NO)]3+. Methods: Aortic rings were contracted with noradrenaline (10−6 M). After voltage stabilization, a single concentration (10−6 M) of the compounds was added to the assay medium. The responses were recorded during 120 min. Vascular integrity was assessed functionally using acetylcholine at 10−6 M and sodium nitroprusside at 10−6 M as well as by histological examination. Results: Histological analysis confirmed the presence or absence of endothelial cells in those tissues. All tetraamine complexes altered the contractile response induced by norepinephrine, resulting in increased tone followed by relaxation. In rings with endothelium, the inhibition of endothelial NO caused a reduction of the contractile effect caused by pyridine NO. No significant responses were observed in rings with endothelium after treatment with cyclan NO. In contrast, in rings without endothelium, the inhibition of guanylate cyclase significantly reduced the contractile response caused by the pyridine NO and cyclan NO complexes, and both complexes caused a relaxing effect. Conclusion: The results indicate that the vascular effect of the evaluated complexes involved a decrease in the vascular tone induced by norepinephrine (10−6 M) at the end of the incubation period in aortic rings with and without endothelium, indicating the slow release of NO from these complexes and suggesting that the ligands promoted chemical stability to the molecule. Moreover, we demonstrated that the association of Ru with NO is more stable when the ligands pyridine and cyclan ...


Fundamento: As tetra-aminas de rutênio cada vez mais se destacam como carreadoras da molécula de óxido nítrico. Desse modo, estudos farmacológicos tornam-se altamente relevantes, afim de melhor compreender o mecanismo de ação envolvido. Objetivo: Avaliar a resposta vascular das tetra-aminas trans-[RuII(NH3)4(Py)(NO)]3+, trans-[RuII(Cl)(NO)(Cyclan)](PF6)2 e trans-[RuII(NH3)4(4-acPy)(NO)]3+. Métodos: Anéis de aorta foram pré-contraídos com noradrenalina (10-6M). Após estabilização da tensão, concentração única (10-6M) dos compostos foi adicionada ao banho de incubação. As respostas foram registradas ao longo de 120 minutos. A integridade vascular foi avaliada funcionalmente (acetilcolina 10-6M; nitroprussiato de sódio 10-6M) e histologicamente Resultados: A análise histológica confirmou a presença ou não de células endoteliais nos tecidos analisados. Todos os complexos alteraram a resposta contrátil induzida pela noradrenalina, resultando em aumento de tônus seguido de efeito relaxante. Em anéis com endotélio, a inibição do óxido nítrico endotelial causou redução do efeito contrátil da piridina óxido nítrico. Não foram observadas respostas significativas em anéis com endotélio referente ao composto cyclan óxido nítrico. Por outro lado, em anéis sem endotélio, a inibição da guanilato ciclase reduziu significativamente a resposta contrátil dos complexos piridina óxido nítrico e cyclan óxido nítrico, levando ambos os compostos a um efeito relaxante. Conclusão: Os resultados obtidos demonstram que o efeito vascular dos complexos avaliados apresentaram diminuição no tônus vascular induzido pela noradrenalina (10-6M) ao final do tempo de incubação, em anéis com e sem endotélio, indicando liberação lenta da molécula de óxido nítrico do composto estudado e sugerindo que os ligantes causaram estabilidade química à molécula. Demonstramos que a ligação rutênio óxido nítrico é mais estável quando utilizamos os ligantes piridina e cyclan para a formulação ...


Subject(s)
Animals , Humans , Mice , Apoptosis/physiology , MicroRNAs/physiology , Endothelial Cells/physiology , MicroRNAs/antagonists & inhibitors , MicroRNAs/metabolism , Molecular Targeted Therapy/methods , Neoplasms/physiopathology , Ribonuclease III/deficiency , Ribonuclease III/physiology , Up-Regulation , Vascular Endothelial Growth Factor A/physiology
7.
Arq. bras. cardiol ; 101(2): 141-148, ago. 2013. ilus, tab
Article in Portuguese | LILACS | ID: lil-685389

ABSTRACT

FUNDAMENTO: O fator de crescimento endotelial vascular (VEGF - vascular endothelial growth factor) induz a mobilização de células progenitoras endoteliais (CPEs) com capacidade de proliferação e diferenciação em células endoteliais, contribuindo, dessa forma, para o processo angiogênico. OBJETIVO: Buscamos avaliar o comportamento de CPEs em pacientes com doença cardíaca isquêmica e angina refratária que receberam injeções intramiocardicas de 2000 µg de VEGF165 como terapia única. MÉTODOS: O estudo foi uma subanálise de um ensaio clínico. Pacientes com doença cardíaca isquêmica avançada e angina refratária foram avaliados para inclusão no estudo. Os critérios de inclusão foram: sinais e sintomas de angina e/ou insuficiência cardíaca apesar de tratamento medicamentoso máximo e área de isquemia miocárdica de, no mínimo, 5% conforme avaliado por uma tomografia computadorizada por emissão de fóton único (TCEFU). Os critérios de exclusão foram: idade > 65 anos, fração de ejeção do ventrículo esquerdo < 25% e cancer diagnosticado. Os pacientes cujos níveis de CPE foram avaliados foram incluídos. A intervenção consistiu na administração de 2000 µg de VEGF 165 de plasmídeo injetado no miocárdio isquêmico. A frequência de células CD34+/KDR+ foi analisada por citometria de fluxo antes e 3, 9, e 27 dias após a intervenção. RESULTADOS: Um total de 9 pacientes foram incluídos, 8 homens, média de idade de 59,4 anos, fração de ejeção ventricular esquerda de 59,3%, e classe de angina predominante III. Observou-se um aumento significativo dos níveis de CPEs no terceiro dia após a intervenção. Todavia, 9 e 27 dias após a intervenção, os níveis de CPEs foram similares aos basais. CONCLUSÃO: Identificamos uma mobilização transitória de CPE, com pico no terceiro dia após a intervenção com VEGF 165 em pacientes com angina refratária. Todavia, os níveis de CPEs apresentaram-se semelhantes aos basais 9 e 27 dias após a intervenção.


BACKGROUND: Vascular endothelial growth factor (VEGF) induces mobilization of endothelial progenitor cells (EPCs) with the capacity for proliferation and differentiation into mature endothelial cells, thus contributing to the angiogenic process. OBJECTIVE: We sought to assess the behavior of EPCs in patients with ischemic heart disease and refractory angina who received an intramyocardial injections of 2000 µg of VEGF 165 as the sole therapy. METHODS: The study was a subanalysis of a clinical trial. Patients with advanced ischemic heart disease and refractory angina were assessed for eligibility. Inclusion criteria were as follows: signs and symptoms of angina and/or heart failure despite maximum medical treatment and a myocardial ischemic area of at least 5% as assessed by single-photon emission computed tomography (SPECT). Exclusion criteria were as follows: age > 65 years, left ventricular ejection fraction < 25%, and a diagnosis of cancer. Patients whose EPC levels were assessed were included. The intervention was 2000 µg of VEGF 165 plasmid injected into the ischemic myocardium. The frequency of CD34+/KDR+ cells was analyzed by flow cytometry before and 3, 9, and 27 days after the intervention. RESULTS: A total of 9 patients were included, 8 males, mean age 59.4 years, mean left ventricular ejection fraction of 59.3% and predominant class III angina. The number of EPCs on day 3 was significantly higher than that at baseline (p = 0.03); however, that on days 9 and 27 was comparable to that at baseline. CONCLUSION: We identified a transient mobilization of EPCs, which peaked on the 3th day after VEGF 165 gene therapy in patients with refractory angina and returned to near baseline levels on days 9 and 27.


Subject(s)
Female , Humans , Male , Middle Aged , Angina Pectoris/therapy , Cell Movement/genetics , Endothelial Cells/physiology , Genetic Therapy/methods , Multipotent Stem Cells/physiology , Vascular Endothelial Growth Factor A/genetics , Cell Movement/physiology , Multipotent Stem Cells/cytology , Myocardial Ischemia/therapy , Neovascularization, Physiologic/genetics , Plasmids/genetics , Time Factors , Treatment Outcome
8.
Acta cir. bras ; 28(3): 167-173, Mar. 2013. ilus, tab
Article in English | LILACS | ID: lil-667925

ABSTRACT

PURPOSE: To investigate the effects of ischemic preconditioning (IPC) on the expression of pro and anti-apoptotic genes in rat endothelial cells undergoing enteric ischemia (I) and reperfusion (R). METHODS: Thirty rats underwent clamping of the superior mesenteric vessels. Sham group (GS) laparotomy only; Ischemia (GI): intestinal ischemia (60 min); Ischemia and Reperfusion (GIR): ischemia (60 min) and reperfusion (120 min); Ischemia and intestinal ischemic preconditioning (GI + IPC) : 5 minutes of ischemia followed by 10 min of reperfusion before sustained ischemia (60 min) ischemia and reperfusion and IPC (GIR + IPC): 5 min ischemia followed by 10 min of reperfusion before sustained ischemia (60min) and reperfusion (120 min). Rat Endothelial Cell Biology (PCR array) to determine the expression of genes related to endothelial cell biology. RESULTS: Gene expression of pro-apoptotic markers (Casp1, Casp6, Cflar, Fas, and Pgl) was down regulated in GI+IPC and in GIR + IPC. In contrast, the expression of anti-apoptotic genes (Bcl2 and Naip2), was up-regulated in GI + IPC and in GIR + IPC. CONCLUSION: Ischemic preconditioning may protect against cell death caused by ischemia and reperfusion.


Subject(s)
Animals , Male , Rats , Apoptosis/genetics , Endothelial Cells/physiology , Gene Expression/genetics , Intestines/blood supply , Ischemic Preconditioning/methods , Reperfusion Injury/genetics , Random Allocation , Rats, Wistar , Real-Time Polymerase Chain Reaction , Reproducibility of Results , Reperfusion Injury/prevention & control , Time Factors
9.
Article in English | IMSEAR | ID: sea-144663

ABSTRACT

Background & objectives: Nutritional compounds which display anti-inflammatory and antioxidant effects have specific applications in preventing oxidative stress and endothelial dysfunction. In this study we evaluated the effect of Lisosan G (powder of Triticum sativum grains) on human microvascular endothelial cells (HMEC-1) exposed to oxidized low density lipoprotein (ox-LDL). Methods: The protective effects of Lisosan G were evaluated on human microvascular endothelial cells exposed to ox-LDL. Intercellular adhesion molecular-1 (ICAM-1), endothelin-1 (ET-1), and interleukin-6 (IL-6) concentrations and the expression of the respective genes were evaluated in response to incubation with ox-LDL, after co-incubation with ox-LDL and Lisosan G or exposed to Lisosan G alone. The analysis of LOX-1 gene was performed with RT-PCR semi quantitative method. The degree of oxidation induced in relation to control, was established by measurement of malondialdehyde (MDA) production. Results: The incubation with ox-LDL induced a significant increase in ICAM-1, IL-6 and ET-1 levels compared to the basal condition (P<0.01, P<0.05, and P<0.01, respectively), while in presence of Lisosan G, ICAM-1 levels showed a significant reduction both compared to the cultures treated with ox-LDL and control (P<0.01). IL-6 levels did not show any difference; ET-1 levels showed a partial reduction after co-treatment with Lisosan G, and also with Lisosan G alone, reduced the concentration below control (P<0.01). The modulation of these markers was confirmed by RT-PCR analysis. An association between MDA formation and the three markers production was observed. Semi-quantitative analysis of LOX-1 gene expression showed a significant up-regulation only after ox-LDL exposure. Interpretation & conclusions: The results demonstrate that Lisosan G may have an important role in the prevention of microcirculatory dysfunction.


Subject(s)
Analysis of Variance , Biomarkers/metabolism , Cell Line , Endothelial Cells/drug effects , Endothelial Cells/physiology , Endothelin-1/metabolism , Humans , Intercellular Adhesion Molecule-1/metabolism , Interleukin-6/metabolism , Lipoproteins, LDL/metabolism , Microcirculation/drug effects , Microcirculation/physiology , Microvessels/cytology , Plant Extracts/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Scavenger Receptors, Class E/metabolism
10.
Arq. bras. cardiol ; 98(2): 182-191, fev. 2012. ilus, tab
Article in Portuguese | LILACS | ID: lil-614517

ABSTRACT

O exercício físico mobiliza Células Progenitoras Endoteliais (CPE) para o sangue periférico. Entretanto, esse efeito parece depender de características do exercício, como duração e intensidade. O objetivo do presente trabalho foi verificar, por meio de revisão sistemática, o impacto de uma única sessão de exercício aeróbico sobre a mobilização de CPE em indivíduos sadios e os potenciais mecanismos envolvidos. A busca bibliográfica foi realizada nas bases de dados eletrônicas SciELO, LILACS, Cochrane, ClinicalTrials.gov, SPORTDiscus e Medline, em maio de 2011. Dos 178 estudos inicialmente identificados, 12 atenderam aos critérios de inclusão e foram classificados quanto à qualidade mediante critérios da escala PEDro. A magnitude e a duração da resposta de mobilização das CPE foram maiores após a realização de exercícios de longa/ultralonga duração e estão correlacionadas com níveis plasmáticos de fator de crescimento endotélio vascular (VEGF). O pico de mobilização dessas células em resposta a uma sessão de exercício máximo ou submáximo, com duração de até uma hora, ocorre no período imediatamente após o esforço até uma hora após sua interrupção. Um possível mecanismo é a biodisponibilidade do Óxido Nítrico (NO). A idade dos indivíduos e a intensidade do exercício parecem interferir na resposta de mobilização das CPE. Exercícios de longa/ultralonga duração promovem mobilização mais acentuada das CPE quando comparados a exercícios máximos ou submáximos. Os mecanismos envolvem a liberação do VEGF em exercícios de longa/ultralonga duração e a biodisponibilidade de NO em exercícios máximo e submáximo com até uma hora de duração.


Physical exercise mobilizes endothelial progenitor cells (EPCs) to peripheral blood. However, this effect seems to depend on exercise characteristics, such as duration and intensity. The aim of this systematic review was to verify the impact of a single bout of aerobic exercise on the mobilization of EPCs in healthy individuals, and the potential mechanisms involved. The bibliographic search was conducted on the following electronic databases in May 2011: SciELO, LILACS, Cochrane, ClinicalTrials.gov, SPORTDiscus and Medline. Of the 178 articles initially identified, 12 met the inclusion criteria and were classified regarding quality according to the PEDro scale. The magnitude and duration of the EPC mobilization response were higher after long/ultralong duration exercises, and they are correlated with vascular endothelial growth factor (VEGF) plasma levels. The EPC mobilization peak in response to a maximal or submaximal single bout of exercise lasting up to one hour occurs immediately after the exercise or within the first hour after it. One possible mechanism is nitric oxide (NO) bioavailability. The individuals' age and exercise intensity seem to interfere with the EPC mobilization response. Long/ultralong duration exercises promote more pronounced EPC mobilization as compared with maximal or submaximal exercises. The mechanisms involve VEGF release in long/ultralong duration exercises and NO bioavailability in maximal or submaximal exercises lasting less than one hour.


El ejercicio físico moviliza Células Progenitoras Endoteliales (CPE) hacia la sangre periférica. Entre tanto, ese efecto parece depender de características del ejercicio, como duración e intensidad. El objetivo de este estudio fue verificar, por medio de revisión sistemática, el impacto de una única sesión de ejercicio aeróbico sobre la Movilización de CPE en individuos sanos y los potenciales mecanismos envueltos. La búsqueda bibliográfica fue realizada en las bases de datos electrónicas SciELO, LILACS, Cochrane, ClinicalTrials.gov, SPORTDiscus y Medline, en mayo de 2011. De los 178 estudios inicialmente identificados, 12 respondieron a los criterios de inclusión y fueron clasificados en cuanto a la calidad mediante criterios de la escala PEDro. La magnitud y la duración de la respuesta de Movilización de las CPE fueron mayores después de la realización de ejercicios de larga/ultra larga duración y están correlacionadas con niveles plasmáticos de factor de crecimiento endotelio vascular (VEGF). El pico de Movilización de esas células en respuesta a una sesión de ejercicio máximo o submáximo, con duración de hasta una hora, ocurre en el período inmediatamente después del esfuerzo y hasta una hora después de su interrupción. Un posible mecanismo es la biodisponibilidad del Óxido Nítrico (NO). La edad de los individuos y la intensidad del ejercicio parecen interferir en la respuesta de Movilización de las CPE. Ejercicios de larga/ultra larga duración promueven Movilización más acentuada de las CPE cuando son comparados a ejercicios máximos o submáximos. Los mecanismos envuelven la liberación del VEGF en ejercicios de larga/ultra larga duración y la biodisponibilidad de NO en ejercicios máximo y submáximo con hasta una hora de duración.


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Humans , Middle Aged , Young Adult , Cell Movement/physiology , Endothelial Cells/physiology , Exercise/physiology , Nitric Oxide/metabolism , Vascular Endothelial Growth Factor A/blood , Endothelial Cells/cytology , Time Factors
12.
Rev. cuba. hematol. inmunol. hemoter ; 26(4): 256-275, Oct.-Dec. 2010.
Article in Spanish | LILACS | ID: lil-584711

ABSTRACT

Se presentan los conceptos actuales sobre las células madre provenientes de la médula ósea y la importancia de las células estromales en la Medicina Regenerativa. Se describen, en particular, las características fenotípicas de las células madre mesenquimales y endoteliales, así como las de diferentes tipos celulares relacionados, sus propiedades funcionales y la importancia dada al uso de estas células en diversas aplicaciones terapéuticas. Se refieren los resultados de su estudio en distintos estados patológicos, las variaciones por la acción de drogas y de los factores de crecimiento, y su potencialidad futura en el diagnóstico y tratamiento de diferentes enfermedades


The current concepts on the stem cells from bone marrow and the significance of the stromal cells in Regenerative Medicine are showed. In particular, the phenotypical features of mesenchymal and endothelial stem cells are described, as well as the different related types of cells, its functional and the significance properties given to use of these cells in different therapeutic applications. The results of study in different pathologic states, the variations due to drugs action and of the growth factors are recounted as well as its future potential in diagnosis and treatment of different diseases


Subject(s)
Humans , Endothelial Cells/physiology , Bone Marrow Cells/physiology , Mesenchymal Stem Cells/physiology , Regenerative Medicine/trends
13.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 20(2): 158-165, abr.-jun. 2010. ilus
Article in Portuguese | LILACS | ID: lil-570202

ABSTRACT

A disfunção endotelial está associada ao desenvolvimento e às complicações da aterosclerose e pode ser um marcador do risco cardiovascular. Em situação fisiológica, ocorre equilíbrio entre a erosão da monocamada de células endoteliais e a capacidade de reposição dessas células para a manutenção da homeostase vascular; porém, quando a perda do endotélio, quer por erosão quer por apoptose, superar a capacidade de reposição celular ou se as células endoteliais não preservarem suas propriedades características, ocorre disfunção endotelial. Biomarcadores de função endotelial prompreendem características das células endotelial que possam ser mensuradas. Entre os novos biomarcadores da função endotelial, um grupo de marcadores do turnover dessas células tem sido proposto: células progenitoras endoteliais, células endoteliais circulantes e micropartículas de diferentes populações celulares, células progenitoras endoteliais, células endoteliais circulantes e micropartículas oferecem um meio não-invasivo para estimar a competência vascular. Níveis de células progenitoras endoteliais podem aumentar em eventos agudos, como o infarto...


Endothelial dysfunction is associated with the development of atherosclerosis complications and may be a marker of cardiovascular risk. In physiological conditions there is a balance between the erosion of the endothelial cell monolayer and the ability of the regenerated endothelium to maintain vascular homeostasis; however, when there is loss of endothelial cells, due to erosion or to apoptosis, surpassing the capacity of endothelial regrowth, or if these cells do not preserve their protective characteristics, the endothelium becomes dysfunctional. Endothelial function biomarkers comprise measurable characteristics of endothelial cells. Among new biomarkers of endothelial function, a group of markers of the turnover of these cells has been proposed: endothelial progenitor cells, circulating endothelial cells, and microparticles of different cell populations. As mediators of endothelial homeostasis, endothelial progenitor cells, circulating endothelial cells and microparticles are non-invasive means to estimate vascular competence. Endothelial progenitor cell levels may increase in acute events, such as in acute myocardial infarction or in vascular injury. However, cardiovascular risk factors reduce the number of endothelial progenitor cells. Microparticles are small fragments released by activated or apoptotic cells (endothelial cells, platelets, etc.) found in healthy individuals and among those with cardiovascular diseases. Platelets are the cells that release the greatest amount of microparticles in the blood, although other cell populations also produce microparticles. Higher levels of endothelial microparticles have been found in acute coronary syndrome, peripheral arterial disease and in patients with cardiovascular risk factors...


Subject(s)
Humans , Atherosclerosis/complications , Bone Marrow , Endothelial Cells/physiology , Endothelium/abnormalities , Biomarkers/analysis , Risk Factors
14.
Article in English | WPRIM | ID: wpr-76617

ABSTRACT

Angiopoietin-1 (Ang1) binds to and activates Tie2 receptor tyrosine kinase. Ang1-Tie2 signal has been proposed to exhibit two opposite roles in the controlling blood vessels. One is vascular stabilization and the other is vascular angiogenesis. There has been no answer to the question as to how Tie2 induces two opposite responses to the same ligand. Our group and Dr. Alitalo's group have demonstrated that trans-associated Tie2 at cell-cell contacts and extracellular matrix (ECM)-anchored Tie2 play distinct roles in the endothelial cells. The complex formation depends on the presence or absence of cell-cell adhesion. Here, we review how Ang1-Tie2 signal regulates vascular maintenance and angiogenesis. We further point to the unanswered questions that must be clarified to extend our knowledge of vascular biology and to progress basic knowledge to the treatment of the diseases in which Ang1-Tie2-mediated signal is central.


Subject(s)
Angiopoietin-1/physiology , Animals , Cell Adhesion/physiology , Cell Movement/physiology , Endothelial Cells/physiology , Endothelium, Vascular/physiology , Extracellular Matrix/metabolism , Humans , Neovascularization, Physiologic/physiology , Receptor, TIE-2/physiology , Signal Transduction/physiology
15.
Rev. bras. cir. cardiovasc ; 23(4): 467-473, out.-dez. 2008. ilus
Article in English, Portuguese | LILACS | ID: lil-506028

ABSTRACT

OBJETIVO: As células progenitoras endoteliais (CPE), caracterizadas pelo marcador CD133+, contribuem para a neovascularização, e o aumento no número dessas células pode ser uma ferramenta terapêutica promissora. O sangue de cordão umbilical humano contém um número significante de CPE, sugerindo a possibilidade do uso destas células para a revascularização de tecidos isquêmicos. O objetivo desse trabalho foi analisar a funcionalidade das células CD133+ diferenciadas in vitro. MÉTODOS: As células diferenciadas foram caracterizadas por citometria de fluxo; a expressão do mRNA de VEGF foi avaliada por RT-PCR e a funcionalidade, por meio de ensaios de formação de túbulos capilares. RESULTADOS: As células diferenciadas perderam os marcadores de CPE, mantiveram em níveis baixos os marcadores das linhagens hematopoética e monocíticas e aumentaram a expressão dos marcadores de células endoteliais adultas. As células diferenciadas apresentaram transcritos no mRNA de VEGF e mostraram-se capazes de formar túbulos capilares in vitro. CONCLUSÃO: As células CD133+ diferenciadas in vitro em células endoteliais demonstraram serem funcionalmente ativas, abrindo perspectiva para seu uso futuro em aplicações terapêuticas.


OBJECTIVE: Endothelial progenitor cells (EPC) caracterized by the CD133+ marker, contribute to the neovascularization. Increasing EPC number in vitro could be a promising therapeutic tool. Human umbilical cord blood maintains a significant number of EPC, suggesting the possibility to use these cells to induce the revascularization of ischemic tissues. The aim of this study was to analize the in vitro function of differentiated CD133+ cells. METHODS: Cells were characterized by flow cytometry, VEGF mRNA expression was evaluated by the RT-PCR analysis and the functionally by essays of capillary tubes formation. RESULTS: Differentiated cells lost EPC markers, maintained low levels of markers for hematopoietic and monocytic cell lines and increased the expression of adult endothelial cell markers. Differentiated cells expressed VEGF mRNA and were capable to induce in vitro capillary tubules formation. CONCLUSION: CD133+ cells differentiated into endothelial cells in vitro are functionally active initiating the possibility of their use in future therapeutic applications.


Subject(s)
Adolescent , Adult , Female , Humans , Young Adult , Antigens, CD , Cell Differentiation/physiology , Endothelial Cells/physiology , Fetal Blood/cytology , Glycoproteins , Neovascularization, Physiologic , Peptides , Stem Cells/physiology , Capillaries , Cells, Cultured , Flow Cytometry , Parturition , Reverse Transcriptase Polymerase Chain Reaction , RNA, Messenger/metabolism , Stem Cells/cytology , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/metabolism , Young Adult
16.
Gac. méd. Caracas ; 116(2): 134-142, jun. 2008. ilus
Article in Spanish | LILACS | ID: lil-630532

ABSTRACT

Las lesiones vasculares benignas son básicamente hemangiomas y malformaciones vasculares. El diagnóstico preciso permite el tratamiento más adecuado a cada paciente. El conocimiento de las diferentes formas de presentación es importante para el éxito en el manejo de estas lesiones vasculares


Benign vascular lesions are mainly hemangiomas and vascular malformations. Knowing the different clinical presentations is extremely important and will allow making the right diagnosis and, in consequence, applying the proper treatment


Subject(s)
Humans , Male , Adult , Female , Child , Middle Aged , Endothelial Cells/physiology , Vascular Malformations/diagnosis , Vascular Neoplasms/pathology , Magnetic Resonance Angiography/methods , Dermis/anatomy & histology , Hemangioma/pathology
17.
Arq. bras. cardiol ; 90(6): 443-450, jun. 2008. ilus, graf
Article in English, Portuguese | LILACS | ID: lil-485191

ABSTRACT

A hipertrofia ventricular esquerda (HVE) ocorre em reposta à sobrecarga hemodinâmica relatada em várias condições fisiológicas e patológicas. Entretanto, ainda não está completamente elucidado se o estímulo primário para a hipertrofia é o estiramento mecânico do coração, fatores neuro-humorais, ou mesmo a interação de ambos. Esses fatores são traduzidos no interior da célula como alterações bioquímicas que levam à ativação de segundos (citosólicos) e terceiros (nucleares) mensageiros que irão agir no núcleo da célula, regulando a transcrição, e finalmente determinarão a expressão gênica que induza HVE. A HVE é caracterizada por alterações estruturais decorrentes do aumento das dimensões dos cardiomiócitos, da proliferação do tecido conjuntivo intersticial e da rarefação da microcirculação coronariana. Nos últimos anos, o óxido nítrico (•NO) surgiu como um importante regulador do remodelamento cardíaco, especificamente reconhecido como um mediador anti-hipertrófico. Vários estudos têm demonstrado os alvos celulares, as vias de sinalização anti-hipertrófica e o papel funcional do •NO. Portanto, a HVE parece desenvolver-se em decorrência da perda do balanço entre as vias de sinalização pró e anti-hipertróficas. Esses novos conhecimentos sobre as vias de sinalização pró e anti-hipertróficas permitirão desenvolver novas estratégicas no tratamento das HVE patológicas.


The left ventricular hypertrophy (LVH) occurs in response to the hemodynamic overload in some physiological and pathological conditions. However, it has not been completely elucidated whether the primary stimulation for the hypertrophy is the mechanical stretching of the heart, neurohumoral factors, or even the interaction of both. These factors are translated inside the cell as biochemical alterations that lead to the activation of second (cytosolic) and third (nuclear) messengers that will act in the cell nucleus, regulating transcription, and will finally determine the genic expression that induces LVH. The LVH is characterized by structural alterations due to the increase in the cardiomyocyte dimensions, the proliferation of the interstitial connective tissue and the rarefaction of the coronary microcirculation. Recently, nitric oxide (•NO) has appeared as an important regulator of cardiac remodeling, specifically recognized as an anti-hypertrophic mediator. Some studies have demonstrated the cellular targets, the anti-hypertrophic signaling pathways and the functional role of •NO. Thus, the LVH seems to develop as a result of the loss of the balance between the pro and the anti-hypertrophic signaling pathways. This new knowledge about the pro and anti-hypertrophic signaling pathways will allow the development of new strategies in the treatment of pathological LVH.


Subject(s)
Animals , Humans , Hypertrophy, Left Ventricular/etiology , Myocytes, Cardiac/physiology , Nitric Oxide Synthase/physiology , Nitric Oxide/physiology , Endothelial Cells/physiology , Hemodynamics , Hypertension/complications , Hypertrophy, Left Ventricular/metabolism , Hypertrophy, Left Ventricular/physiopathology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide/biosynthesis , Oxidative Stress , Ventricular Remodeling/physiology
18.
Article in English | WPRIM | ID: wpr-635035

ABSTRACT

To examine the changes in number and function of endothelial progenitor cells (EPCs) from peripheral blood (PB) in hypertension disorder complicating pregnancy (HDCP), 20 women with HDCP and 20 normal pregnant women at the third trimester were studied. Mononuclear cells (MNCs) from PB were isolated by Ficoll density gradient centrifugation. EPCs were identified by positive expression of both CD34 and CD133 under fluorescence microscope and positive expression of factor VIII as shown by immunocytochemistry. The number of EPCs was flow-cytometrically determined. Proliferation and migration of EPCs were measured by MTT assay and modified Boyden chamber assay, respectively. The adhesion activity of EPCs was detected by counting the number of the adherent cells. The results showed that, compared with normal pregnant women, the number of EPCs was significantly reduced in HDCP (4.29%+/-1.21% vs 15.32%+/-2.00%, P<0.01), the functional activity of EPCs in HDCP, such as proliferation (13.45%+/-1.68% vs 18.45%+/-1.67%), migration (37.25+/-7.28 cells/field vs 67.10+/-9.55 cells/field) and adhesion activity (20.65+/-5.19 cells/field vs 34.40+/-6.72 cells/filed) was impaired (P<0.01). It is concluded that the number and function of EPCs are significantly decreased in HDCP.


Subject(s)
Antigens, CD/metabolism , Antigens, CD34/metabolism , Case-Control Studies , Cell Adhesion , Cell Count , Cell Movement , Endothelial Cells/pathology , Endothelial Cells/physiology , Glycoproteins/metabolism , Hypertension, Pregnancy-Induced/pathology , Peptides/metabolism , Stem Cells/pathology , Stem Cells/physiology
19.
Indian Heart J ; 2007 Nov-Dec; 59(6): 475-81
Article in English | IMSEAR | ID: sea-3124

ABSTRACT

OBJECTIVE: The present study correlated the functional ability of culture-enriched EPCs to form colonies (EPC-CFUs), with risk factors and severity of CAD. METHODS: Blood mononuclear cells from healthy controls (n = 16) and patients with CAD (n =35) were cultured for seven days for the formation of EPC-CFUs. After the characterization of EPCs, the number of EPC-clusters were compared in the study groups and correlated with the presence or absence of individual CAD risk factors, total vascular risk score (TVRS) and the severity of CAD in patients with CAD by Student's 't' test and regression analysis. RESULTS: As compared to the patients, the controls showed significantly greater formation of EPC-CFUs. Patients with hypertension and smoking had significant reduction in the number of EPC-CFUs as compared to patients without these risk factors (p < 0.05). A negative correlation between TVRS and number of EPC-CFUs (r = -0.74, p < 0.05) and also between number of stenosing coronary arteries and EPC-CFUs (r = -0.42, p = 0.05) were observed. On multivariate analysis, however, only TVRS appeared to be a significant predictor of reduced formation of EPC-CFUs. CONCLUSION: The present study suggests that more is the number of CAD risk factors, lesser is the formation of EPC-clusters in culture.


Subject(s)
Aged , Case-Control Studies , Cells, Cultured , Coronary Artery Disease/physiopathology , Endothelial Cells/physiology , Female , Humans , Male , Middle Aged , Regression Analysis , Risk Factors , Statistics, Nonparametric , Stem Cells/physiology
20.
Braz. j. med. biol. res ; 39(9): 1189-1196, Sept. 2006. graf
Article in English | LILACS | ID: lil-435422

ABSTRACT

Hypoxia activates endothelial cells by the action of reactive oxygen species generated in part by cyclooxygenases (COX) production enhancing leukocyte transmigration. We investigated the effect of specific COX inhibition on the function of endothelial cells exposed to hypoxia. Mouse immortalized endothelial cells were subjected to 30 min of oxygen deprivation by gas exchange. Acridine orange/ethidium bromide dyes and lactate dehydrogenase activity were used to monitor cell viability. The mRNA of COX-1 and -2 was amplified and semi-quantified before and after hypoxia in cells treated or not with indomethacin, a non-selective COX inhibitor. Expression of RANTES (regulated upon activation, normal T cell expressed and secreted) protein and the protective role of heme oxygenase-1 (HO-1) were also investigated by PCR. Gas exchange decreased partial oxygen pressure (PaO2) by 45.12 ± 5.85 percent (from 162 ± 10 to 73 ± 7.4 mmHg). Thirty minutes of hypoxia decreased cell viability and enhanced lactate dehydrogenase levels compared to control (73.1 ± 2.7 vs 91.2 ± 0.9 percent, P < 0.02; 35.96 ± 11.64 vs 22.19 ± 9.65 percent, P = 0.002, respectively). COX-2 and HO-1 mRNA were up-regulated after hypoxia. Indomethacin (300 æM) decreased COX-2, HO-1, hypoxia-inducible factor-1alpha and RANTES mRNA and increased cell viability after hypoxia. We conclude that blockade of COX up-regulation can ameliorate endothelial injury, resulting in reduced production of chemokines.


Subject(s)
Animals , Mice , Cell Hypoxia/drug effects , Cyclooxygenase 1/drug effects , Cyclooxygenase Inhibitors/pharmacology , /drug effects , Endothelial Cells/metabolism , Indomethacin/pharmacology , Cell Survival , Cyclooxygenase 1/genetics , /genetics , Endothelial Cells/physiology , Gene Expression Regulation, Enzymologic , Heme Oxygenase-1/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Polymerase Chain Reaction , RNA, Messenger , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL